RealHOPE (101007939)
https://cordis.europa.eu/project/id/101007939
Horizon 2020 (2014-2020)
Real World Handling of Protein Drugs - Exploration, Evaluation and Education
Handling of protein drug products and stability concerns (IMI2-2020-20-06)
proteins · pharmacology and pharmacy
2021-07-01 Start Date (YY-MM-DD)
2025-06-30 End Date (YY-MM-DD)
€ 7,132,608 Total Cost
Description
RealHOPE will create an understanding of the real-life handling of protein drugs in hospital pharmacy, clinics and in the hands of patients by applying smart tag technologies. Different parameters will be logged and combined with protein characterisation at different stages, as well as with information from EFPIA partners on their drugs in use. Statistical evaluation of the data will be used to identify patterns in handling that are linked to protein destabilisation occurrence and type of protein degradation. Focus interviews with personnel in hospital pharmacies, clinics and with patients/care givers will be used to understand current handling practice and what the desired handling instructions and limitations are. These insights will be used to design in-use mimicking stability protocols for the protein drugs in the project. Ultra-scaled-down devices for stability assessment will be designed to be used in early phase for efficient development cost effective and safe future protein therapies. Protocols and devices will be validated towards the collected handling data base. Interventions in hospital pharmacies using e.g. compounding robots will be investigated. Techniques to assess e.g. aggregate formation in the final drug preparation situation will be evaluated together with SMEs producing analytical tools and hospital pharmacists. The collected data and interviews will form the base of development of teaching materials directed towards different target groups: hospital pharmacists, nurses and patients/care givers. App developers will be active in this part to design attractive and efficient apps for teaching and collecting therapy performance data.
Complicit Organisations
1 Israeli organisation participates in RealHOPE.Country | Organisation (ID) | VAT Number | Role | Activity Type | Total Cost | EC Contribution | Net EC Contribution |
---|---|---|---|---|---|---|---|
Netherlands | ICU MEDICAL BV (886298119) | NL853783664B01 | participant | PRC | € 2,000 | € 0 | € 0 |
Sweden | REUMATIKERFORBUNDET (908799500) | nan | participant | OTH | € 12,500 | € 12,500 | € 12,500 |
United Kingdom | PFIZER LIMITED (998133396) | GB201048427 | participant | PRC | € 250,000 | € 0 | € 0 |
United States | ABBVIE INC (951044649) | nan | participant | PRC | € 454,000 | € 0 | € 0 |
Germany | SANOFI-AVENTIS DEUTSCHLAND GMBH (997731137) | DE812134551 | participant | PRC | € 1,360,000 | € 0 | € 0 |
Sweden | LUNDS UNIVERSITET (999901318) | SE202100321101 | participant | HES | € 555,522 | € 528,897 | € 528,897 |
United Kingdom | CENTRE FOR PROCESS INNOVATION LIMITED LBG (996621069) | GB888933743 | participant | REC | € 456,035 | € 456,035 | € 456,035 |
Israel | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (923869808) | IL557410149 | participant | PRC | € 75,000 | € 0 | € 0 |
Italy | SOCIETA ITALIANA DI FARMACIA CLINICA E TERAPIA (894234271) | IT09547380965 | participant | OTH | € 17,250 | € 17,250 | € 17,250 |
United Kingdom | UNIVERSITY OF DUNDEE (999975523) | GB270939731 | participant | HES | € 514,968 | € 514,968 | € 514,968 |
Sweden | ASTRAZENECA AB (999941379) | SE556011748201 | participant | PRC | € 350,000 | € 0 | € 0 |
Sweden | RISE RESEARCH INSTITUTES OF SWEDEN AB (999613422) | SE556464687401 | coordinator | REC | € 649,778 | € 649,778 | € 649,778 |
Switzerland | F. HOFFMANN-LA ROCHE AG (999601782) | CHE116267986MWST | participant | PRC | € 240,000 | € 0 | € 0 |
Switzerland | LONZA AG (998904449) | CH468752 | participant | PRC | € 800,000 | € 0 | € 0 |
Italy | UNIVERSITA DEGLI STUDI DI PADOVA (999995602) | IT00742430283 | participant | HES | € 272,500 | € 272,500 | € 272,500 |
Germany | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (999965241) | DE811850788 | participant | PRC | € 200,000 | € 0 | € 0 |
Sweden | ELSA SCIENCE AB (905611886) | SE559105547901 | participant | PRC | € 104,500 | € 104,500 | € 104,500 |
Sweden | PROBATION LABS SWEDEN AB (894379189) | SE556902327701 | participant | PRC | € 41,347 | € 41,347 | € 41,347 |
Italy | PLURIMA SPA (891373353) | IT01698960547 | participant | PRC | € 14,877 | € 14,877 | € 14,877 |
Spain | FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (999477525) | ESG59319681 | participant | REC | € 40,000 | € 40,000 | € 6,250 |
Germany | BOEHRINGER INGELHEIM INTERNATIONALGMBH (998206922) | DE811138149 | participant | PRC | € 230,000 | € 0 | € 0 |
Spain | HOSPITAL CLINIC DE BARCELONA (905096816) | ESQ0802070C | thirdParty | REC | € 33,750 | € 0 | € 33,750 |
Sweden | REGION UPPSALA (998923946) | SE232100002401 | participant | PUB | € 130,445 | € 130,445 | € 130,445 |
Italy | ISTITUTO ONCOLOGICO VENETO (968344405) | IT04074560287 | participant | REC | € 5,000 | € 0 | € 0 |
Italy | AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA 'ISTITUTI OSPITALIERI DI VERONA (973382488) | IT03901420236 | participant | PUB | € 15,285 | € 15,285 | € 15,285 |
United Kingdom | UNIVERSITY COLLEGE LONDON (999975620) | GB524371168 | participant | HES | € 325,348 | € 325,348 | € 325,348 |
Italy | AZIENDA ULSS N3 SERENISSIMA (912319727) | IT02798850273 | participant | PUB | € 16,250 | € 16,250 | € 16,250 |